Planning for decentralized, simplified prEP: Learnings from potential end users in Ga-Rankuwa, gauteng, South Africa

Planning for decentralized, simplified prEP: Learnings from potential end users in Ga-Rankuwa, gauteng, South Africa

BackgroundIn South Africa, youth experience challenges with oral Pre-Exposure Prophylaxis (PrEP) access and uptake. Taking services out of healthcare settings has the potential to increase reach and overcome these challenges. This paper presents young and older people's preferences for decentra...

Full description

Bibliographic Details
Main Authors:	Paballo Mataboge, Susan Nzenze, Nqaba Mthimkhulu, Mbali Mazibuko, Alison Kutywayo, Vusile Butler, Nicolette Naidoo, Saiqa Mullick
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-01-01
Series:	Frontiers in Reproductive Health
Subjects:	hiv prevention dapivirine vaginal ring long-acting cabotegravir decentralized simplified service delivery
Online Access:	https://www.frontiersin.org/articles/10.3389/frph.2022.1081049/full

Similar Items

Factors influencing the uptake of a mono-PrEP implant for the prevention of HIV: Males’ perspectives from three South African provinces
by: Nqaba Mthimkhulu, et al.
Published: (2024-01-01)

Factors influencing the uptake of a mono-PrEP implant for the prevention of HIV: Males' perspectives from three South African provinces.
by: Nqaba Mthimkhulu, et al.
Published: (2024-01-01)

Key programmatic and policy considerations for introducing multipurpose prevention (MPT) methods: reflections from healthcare providers and key stakeholders in South Africa
by: Alison Kutywayo, et al.
Published: (2024-02-01)

Preferences, educational messaging, and demand creation channels for multipurpose-prevention technologies (MPTs) among women in South Africa
by: Paballo Mataboge, et al.
Published: (2023-10-01)

Efficient regulatory approval of two novel HIV prevention interventions in a resource-limited setting: experiences from Zimbabwe
by: Caroline Murombedzi, et al.
Published: (2023-11-01)

Shaping and coordinating the implementation science agenda for injectable cabotegravir for PrEP: the role of the Biomedical Prevention Implementation Collaborative (BioPIC)
by: Mitchell Warren, et al.
Published: (2023-07-01)

Counterfactual estimation of efficacy against placebo for novel PrEP agents using external trial data: example of injectable cabotegravir and oral PrEP in women
by: Deborah Donnell, et al.
Published: (2023-06-01)

Multitasking Pharmacophores Support Cabotegravir-Based Long-Acting HIV Pre-Exposure Prophylaxis (PrEP)
by: Zheng Wan, et al.
Published: (2024-01-01)

Introduction and integration of PrEP and sexual and reproductive health services for young people: Health provider perspectives from South Africa
by: Melanie Pleaner, et al.
Published: (2023-01-01)

Investigating the Contribution of Drug-Metabolizing Enzymes in Drug-Drug Interactions of Dapivirine and Miconazole
by: Guru Raghavendra Valicherla, et al.
Published: (2021-12-01)

Transport and Permeation Properties of Dapivirine: Understanding Potential Drug-Drug Interactions
by: Ruohui Zheng, et al.
Published: (2022-09-01)

Comprehensive Study of Antiretroviral Drug Permeability at the Cervicovaginal Mucosa <i>via</i> an In Vitro Model
by: Constandinos Carserides, et al.
Published: (2022-09-01)

Use of simulated vaginal and menstrual fluids to model in vivo discolouration of silicone elastomer vaginal rings
by: Clare F. McCoy, et al.
Published: (2021-12-01)

Uptake of Contraception Among Adolescent Girls and Young Women PrEP Clients: Leveraging the Opportunity to Strengthen HIV and Sexual and Reproductive Health Integration
by: Melanie Pleaner, et al.
Published: (2021-07-01)

Real-life efficacy and satisfaction of long-acting ART Cabotegravir-Rilpivirine in HIV-infected individuals
by: S. Spampinato, et al.
Published: (2023-12-01)

Method development and validation for Cabotegravir and Rilpivirine by using HPLC and its degradants are characterized by LCMS and FTIR
by: Anuradha Vejendla, et al.
Published: (2021-11-01)

A Pharmacokinetic Dose-Optimization Study of Cabotegravir and Bictegravir in a Mouse Pregnancy Model
by: Haneesha Mohan, et al.
Published: (2022-08-01)

Three-step synthetic procedure to prepare dolutegravir, cabotegravir, and bictegravir
by: Xianheng Wang, et al.
Published: (2022-04-01)

Review The Emerging Profile of Cross-Resistance among the Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors
by: Nicolas Sluis-Cremer
Published: (2014-07-01)

Sexual and reproductive health and rights knowledge, perceptions, and experiences of adolescent learners from three South African townships: qualitative findings from the Girls Achieve Power (GAP Year) Trial [version 2; peer review: 2 approved]
by: Cecilia Milford, et al.
Published: (2022-11-01)

Socio-demographic and social support factors related to substance use in South African in-school adolescents: Insights from the Girls Achieve Power (GAP Year) trial in three peri-urban settings [version 1; peer review: 2 approved]
by: Alison Kutywayo, et al.
Published: (2021-11-01)

Safety surveillance for PrEP in pregnant and breastfeeding women
by: Lee Fairlie, et al.
Published: (2023-09-01)

Physiologically Based Pharmacokinetic Modelling of Cabotegravir Microarray Patches in Rats and Humans
by: Hannah Kinvig, et al.
Published: (2023-11-01)

Could Long-Acting Cabotegravir-Rilpivirine Be the Future for All People Living with HIV? Response Based on Genotype Resistance Test from a Multicenter Italian Cohort
by: Andrea De Vito, et al.
Published: (2022-01-01)

Cabotegravir Exposure of Zebrafish (<i>Danio rerio</i>) Embryos Impacts on Neurodevelopment and Behavior
by: Daniela Zizioli, et al.
Published: (2023-01-01)

Design and synthesis of cabotegravir derivatives bearing 1,2,3-triazole and evaluation of anti-liver cancer activity
by: Huaxia Xie, et al.
Published: (2023-10-01)

Cabotegravir and Rilpivirine Long-Acting Antiretroviral Therapy Administered Every 2 Months is Cost-Effective for the Treatment of HIV-1 in Spain
by: Santiago Moreno, et al.
Published: (2023-07-01)

Mysteries of success for small and medium enterprises in Ga-Rankuwa Township of Pretoria in Gauteng Province, South Africa
by: Pabalelo Selaelo Maesela, et al.
Published: (2016-03-01)

Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in SwitzerlandResearch in context
by: Paul Thoueille, et al.
Published: (2024-01-01)

Long-Acting Injectable Drugs for HIV-1 Pre-Exposure Prophylaxis: Considerations for Africa
by: Enos Moyo, et al.
Published: (2022-07-01)

What will it take for an injectable ARV to change the face of the HIV epidemic in high‐prevalence countries? Considerations regarding drug costs and operations
by: Gesine Meyer‐Rath, et al.
Published: (2023-07-01)

Securing accelerated access to long‐acting injectable cabotegravir for HIV prevention in low‐ and middle‐income countries
by: Sarah Y. Jenkins, et al.
Published: (2023-07-01)

Immune reconstitution inflammatory syndrome in AIDS patient after successful induction of virological suppression with cabotegravir/rilpivirine
by: Rami Al-Handola, et al.
Published: (2023-07-01)

Long-acting combination of cabotegravir plus rilpivirine: A picture of potential eligible and ineligible HIV-positive individuals from the Italian ARCA cohort
by: Adriana Cervo, et al.
Published: (2023-09-01)

Cabotegravir, the Long-Acting Integrase Strand Transfer Inhibitor, Potently Inhibits Human T-Cell Lymphotropic Virus Type 1 Transmission in vitro
by: Bethany S. Schneiderman, et al.
Published: (2022-04-01)

Contraception knowledge and uptake among in-school adolescents in three South African townships: Baseline findings from the Girls Achieve Power (GAP Year) Trial [version 2; peer review: 1 approved, 2 approved with reservations]
by: Saiqa Mullick, et al.
Published: (2022-07-01)

The prevalence of pregnancy among adolescent girls and young women across the Southern African development community economic hub: A systematic review and meta-analysis
by: Clarence S. Yah, et al.
Published: (2020-11-01)

My PrEP Locator: PrEP directory in Malaysia
by: M.L. Chong, et al.
Published: (2020-12-01)

Decentralizing PrEP delivery: Implementation and dissemination strategies to increase PrEP uptake among MSM in Toronto, Canada.
by: Maxime Charest, et al.
Published: (2021-01-01)

Cabotegravir + Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort
by: Michael G. Sension, et al.
Published: (2023-11-01)